StartupHistory

An open directory of startups through time

Public records · dated sources
Free to read. Free to reuse.

Company records / modularit.bio

Modulari-T

Modulari-T (modularit.bio): 2 changes recorded in its website history since January 2022. Homepage last checked 6 November 2026.

Recorded changes

Newest observations first. Each interval bounds when the website changed; it is not an exact event date.

  1. HeadlineBetween and
    BeforeIN-VIVO DELIVERY of Smart Receptors for Next-Gen Cell & GENE Therapies
    AfterDesigning modular receptors to overcome therapeutic limits in cell therapy

    Observed on the company’s website; business claims are not independently verified.

  2. HeadlineBetween and
    BeforeThis website uses cookies.
    AfterIN-VIVO DELIVERY of Smart Receptors for Next-Gen Cell & GENE Therapies

    Observed on the company’s website; business claims are not independently verified.

First recorded website

Observed 22 January 2022

Our earliest capture with readable facts. This is our first observation, not when the company introduced these things. These website claims are not independently verified.

How it described itself

Modular Antigen Receptor Complex biotechnology

The next step in immunotherapy biotechnology: Modulari-T's modular antigen receptor complex (MARC) platform unlocks the power of the immune system.

All facts above belong to this capture. Unlisted fields mean we have no readable observation, not that they were absent.

How it describes itself

Similar headlines are grouped together. The quote shown is from the last capture in each group, not necessarily the exact wording throughout that period.

  1. Seen February 2026 · 1 capture · latest observed messagingDesigning modular receptors to overcome therapeutic limits in cell therapy

    Unlocking new avenues in In Vivo Cell and Gene Therapy, by combining novel receptors and delivery vehicles developed from the in-depth understanding of the natural modulatory and power of native immun

    This wording observed 1 February 2026.

  2. June 2025 – July 2025 · 2 capturesIN-VIVO DELIVERY of Smart Receptors for Next-Gen Cell & GENE Therapies

    Unlock a new era of safer, cost-effective, and potent treatments for cancer, autoimmune disease and fibrosis

    This wording observed 11 July 2025.

    Inspect 2 captures in this group
    • 21 June 2025 · IN-VIVO DELIVERY of Smart Receptors for Next-Gen Cell & GENE Therapies archived page
    • 11 July 2025 · IN-VIVO DELIVERY of Smart Receptors for Next-Gen Cell & GENE Therapies archived page
  3. Seen January 2022 · 1 captureModular Antigen Receptor Complex biotechnology

    The next step in immunotherapy biotechnology: Modulari-T's modular antigen receptor complex (MARC) platform unlocks the power of the immune system.

    This wording observed 22 January 2022.

Cite this record

StartupHistory, “Modulari-T” company record, https://startuphistory.org/c/modularit.bio

Machine-readable: /c/modularit.bio.json. How changes are found: method.